Hyundai Awarded $400,000 Cancer Grant to Augusta Researcher
The grant supports pediatric brain cancer research led by Dr. Theodore S. Johnson at Augusta University.
Updated on Oct. 2, 2026 in Cancer

Live Poll
Should private corporate funding play a larger role in financing essential medical research?
Hyundai Hope On Wheels has awarded a $400,000 Scholar Hope Grant to Dr. Theodore S. Johnson to advance pediatric brain cancer research. Johnson, who treats patients at the Wellstar Golisano Children's Hospital of Georgia, will utilize the funds to bridge laboratory findings into new clinical treatment approaches.
Why it matters
This grant aims to develop more effective treatment methods for pediatric brain cancer, a critical area of need given that over 15,000 children in the U.S. receive a cancer diagnosis annually. The funding supports translational research performed by physicians who provide direct care to young patients.
This award marks the fifth time Dr. Theodore S. Johnson has received funding from Hyundai Hope On Wheels. The organization, supported by Hyundai Motor America and over 830 U.S. dealers, expects to exceed $303 million in total childhood cancer research contributions in 2026.
The players
Theodore S. Johnson
He is a medical researcher at Augusta University and a practicing physician at the Wellstar Golisano Children's Hospital of Georgia.
Hyundai Hope On Wheels
This is a non-profit organization funded by Hyundai Motor America and its dealership network that focuses on childhood cancer research.
The details
The funds were specifically allocated to the Pediatric Immunotherapy Program at the Georgia Cancer Center at Augusta University. This research focus seeks to improve survival outcomes by transforming innovative laboratory discoveries into practical, bedside treatments for children battling brain cancer.
Timeline
Hyundai Hope On Wheels was founded in 1998.
The organization awarded the grant to Dr. Theodore S. Johnson on October 2, 2026.
Total lifetime donations are projected to surpass $303 million in 2026.
Deeper Dive
The grant supports the ongoing work of the Pediatric Immunotherapy Program at the Georgia Cancer Center. This research aligns with a broader push in oncology to translate high-level laboratory findings into accessible, life-saving therapies for pediatric brain cancer patients.
This research initiative aims to improve treatment options and outcomes for local children currently battling brain cancer. Families at Wellstar Golisano Children's Hospital of Georgia may eventually benefit from the new therapies derived from Dr. Johnson's clinical research.
The takeaway
Translational research grants remain a vital link in moving experimental cancer treatments from the lab to the patient's bedside. Continued private sector support for physicians like Dr. Johnson ensures that innovative care strategies can be tested and applied in real-world pediatric settings.
Further reading
Learn more about the latest research and support initiatives in our Cancer section.
Source note: This article includes information reported by Kicks 99.
Live Poll
Should private corporate funding play a larger role in financing essential medical research?










